Mitochondrial ROS Activates DNA Damage Pathway to Drive Protective Mitophagy
A new PNAS study reveals how mitochondrial free radicals trigger the ATM-CHK2 DNA damage pathway to coordinate three key steps of mitophagy.
Summary
Researchers at China Medical University and University of Pittsburgh discovered that mitochondrial reactive oxygen species (mtROS) act as signaling molecules that activate the ATM-CHK2 DNA damage response (DDR) pathway to drive PINK1/Parkin-dependent mitophagy. CHK2, once activated, phosphorylates three distinct targets: ATAD3A (blocking PINK1 import to initiate mitophagy), OPTN (enhancing recognition of ubiquitinated mitochondria by autophagosomes), and Beclin 1 (promoting autophagosome membrane formation). In CHK2-knockout mice, mitophagy induction was impaired and recovery from renal ischemia-reperfusion injury — a ROS-dependent model — was significantly diminished, demonstrating in vivo relevance.
Detailed Summary
Mitophagy, the selective autophagy of damaged mitochondria, is essential for mitochondrial quality control and redox homeostasis. While it has long been recognized that mitochondrial ROS (mtROS) can trigger mitophagy, the molecular mechanism linking oxidative stress signals to the mitophagy machinery remained poorly understood. This study provides a detailed mechanistic framework showing that mtROS functions not merely as cellular damage but as an adaptive signaling molecule.
The researchers demonstrated that mtROS activates the ataxia-telangiectasia mutated (ATM) kinase and its downstream target cell cycle checkpoint kinase 2 (CHK2) — classically known as a DNA damage response (DDR) pathway. Importantly, this activation occurred even in the absence of overt nuclear DNA damage, positioning the ATM-CHK2 axis as a broader stress sensor. Using genetic tools including CHK2-knockout cells and mice, the team systematically dissected three sequential steps through which CHK2 coordinates mitophagy.
First, CHK2 phosphorylates the mitochondrial membrane protein ATAD3A at Serine 371. This phosphorylation blocks the import of PINK1 into the inner mitochondrial membrane, causing PINK1 to accumulate on the outer mitochondrial membrane — the critical initiating step for PINK1/Parkin-dependent mitophagy. Cells treated with NAC (an mtROS scavenger) showed increased accumulation of damaged mitochondria, confirming that physiological mtROS levels are required for mitochondrial quality control. Second, activated CHK2 phosphorylates the autophagy adaptor Optineurin (OPTN) at Ser177 and Ser473, which enhances OPTN's ability to bind ubiquitinated mitochondria and recruit LC3-positive autophagosomes. Third, CHK2 phosphorylates Beclin 1 at Ser90 and Ser93, promoting autophagosomal membrane formation and completing the autophagic process.
In vivo validation used a renal ischemia-reperfusion (IR) injury model, which generates substantial mtROS. Chk2−/− mice showed significantly impaired mitophagy induction and poorer renal recovery compared to wild-type animals, underscoring the physiological importance of this pathway. These findings establish the ATM-CHK2 DDR pathway as a multi-step coordinator of mitophagy, acting from initiation through cargo recognition to autophagosome biogenesis.
This work has broad implications for understanding aging, neurodegeneration, and ischemic organ injury. Because ATM loss is associated with neurodegenerative diseases marked by mitochondrial dysfunction and impaired mitophagy, this pathway may underlie some of those pathologies. The identification of three specific CHK2 phosphorylation targets (ATAD3A-Ser371, OPTN-Ser177/473, Beclin1-Ser90/93) provides concrete therapeutic targets for conditions where mitophagy dysregulation is implicated.
Key Findings
- mtROS activates the ATM-CHK2 DNA damage response pathway to initiate PINK1/Parkin-dependent mitophagy.
- CHK2 phosphorylates ATAD3A at Ser371, blocking PINK1 mitochondrial import and stabilizing PINK1 on the outer membrane.
- CHK2 phosphorylates autophagy adaptor OPTN at Ser177 and Ser473, enhancing ubiquitinated mitochondria targeting to autophagosomes.
- CHK2 phosphorylates Beclin 1 at Ser90/Ser93 to promote autophagosome membrane formation.
- CHK2-knockout mice show impaired mitophagy and reduced recovery from renal ischemia-reperfusion injury.
Methodology
The study used human cell lines with genetic knockouts (CHK2, ATAD3A, OPTN, Beclin 1 mutants) alongside pharmacological tools (NAC, ATM/CHK2 inhibitors) to dissect the pathway in vitro. In vivo validation employed Chk2−/− mice in a renal ischemia-reperfusion injury model. Mechanistic analyses included co-immunoprecipitation, phospho-specific antibodies, mitochondrial import assays, and mitophagy flux reporters.
Study Limitations
The study is primarily conducted in cell lines and a single mouse model (renal IR injury), so generalizability to other tissues and disease contexts requires further validation. The relative contribution of the CHK2-mediated pathway versus other known mitophagy regulators (e.g., TBK1) under different stress conditions is not fully resolved. Long-term consequences of CHK2 activation on genomic stability versus mitochondrial health were not explored.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.